Skip to main content

Moderna, Inc.

MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001682852

In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $49.2M in total
Insiders trading
4
Net value
−$49.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Moderna, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoge StephenPresident1,562,029Sep 16, 202613
Mock James MChief Financial Officer59,375Sep 14, 202616
Klinger Shannon ThymeChief Legal Officer81,340Sep 8, 202612
Bancel StephaneChief Executive Officer6,440,260Aug 7, 20264
McDonnell Michael RDirector–Jul 10, 20261
Banque Soria EsterChief Commercial Officer–Jul 7, 20261
Afeyan NoubarDirector3,924IndirectMay 22, 20263
Tallett Elizabeth EDirector4,761May 8, 20262
Nader FrancoisDirector32,781May 8, 20262
Rubenstein David M.Director9,643May 8, 20262
Nabel Elizabeth GDirector19,317May 8, 20262
Horning SandraDirector18,585May 8, 20262
Hussain AbbasDirector12,066May 8, 20264
Sagan PaulDirector312,027IndirectMay 1, 20250
Langer RobertDirector11,467,664May 7, 20240
Berenson StephenDirector22,203May 7, 20240
Garay ArpaChief Commercial Officer3,690Dec 7, 20230
Andres JuanSee remarks12,803Dec 30, 20220
Burton PaulChief Medical Officer954Nov 8, 20220
Meline David WChief Financial Officer2,857Aug 11, 20220
Zaks Tal ZviChief Medical Officer0Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 26, 2022 (view filing)Jul 251 dayHoge StephenPresidentSSale−10.0K$162.75−$1.63M−0.6%1.62M after
Jul 29, 2022 (view filing)Jul 272 daysAfeyan NoubarDirectorSSale−10.0K$161.00−$1.61M−0.4%2.48M after
Jul 29, 2022 (view filing)Jul 27-282 daysBancel StephaneChief Executive OfficerSSale−80.0K$156.53−$12.5M−1.5%5.41M after12 lots
Jul 29, 2022 (view filing)Jul 281 dayBancel StephaneChief Executive OfficerSSale−10.0K$157.00−$1.57M−0.1%6.78M after
Jul 29, 2022 (view filing)Jul 272 daysAndres JuanSee remarksSSale−2.00K$161.00−$322.0K−16.2%10.4K after
Aug 5, 2022 (view filing)Aug 32 daysAfeyan NoubarDirectorSSale−10.0K$167.99−$1.68M−0.4%2.47M after
Aug 5, 2022 (view filing)Aug 32 daysAndres JuanSee remarksSSale−2.00K$167.99−$336.0K−16.2%10.4K after
Aug 5, 2022 (view filing)Aug 3-42 daysBancel StephaneChief Executive OfficerSSale−80.0K$189.87−$15.2M−1.5%5.41M after12 lots
Aug 5, 2022 (view filing)Aug 41 dayBancel StephaneChief Executive OfficerSSale−10.0K$185.75−$1.86M−0.1%6.77M after
Aug 9, 2022 (view filing)Aug 81 dayBurton PaulChief Medical OfficerSSale−865$185.10−$160.1K−53.8%744 after
Aug 11, 2022 (view filing)Aug 101 dayMeline David WChief Financial OfficerSSale−164$173.66−$28.5K−5.4%2.86K after
Aug 11, 2022 (view filing)Aug 101 dayAndres JuanSee remarksSSale−2.20K$174.05−$383.6K−17.2%10.6K after2 lots
Aug 11, 2022 (view filing)Aug 101 dayHoge StephenPresidentSSale−244$173.66−$42.4K0.0%1.62M after
Aug 12, 2022 (view filing)Aug 102 daysAfeyan NoubarDirectorSSale−10.0K$174.09−$1.74M−0.4%2.46M after
Aug 12, 2022 (view filing)Aug 10-112 daysBancel StephaneChief Executive OfficerSSale−80.0K$173.33−$13.9M−1.5%5.41M after14 lots
Aug 12, 2022 (view filing)Aug 111 dayBancel StephaneChief Executive OfficerSSale−10.0K$174.23−$1.74M−0.1%6.76M after
Aug 16, 2022 (view filing)Aug 12-154 daysHoge StephenPresidentSSale−10.0K$172.77−$1.73M−0.6%1.62M after2 lots
Aug 19, 2022 (view filing)Aug 172 daysAfeyan NoubarDirectorSSale−10.0K$165.24−$1.65M−0.4%2.45M after
Aug 19, 2022 (view filing)Aug 17-182 daysBancel StephaneChief Executive OfficerSSale−80.0K$154.98−$12.4M−1.5%5.41M after11 lots
Aug 19, 2022 (view filing)Aug 181 dayBancel StephaneChief Executive OfficerSSale−10.0K$157.00−$1.57M−0.1%6.75M after
Aug 19, 2022 (view filing)Aug 172 daysAndres JuanSee remarksSSale−2.00K$165.24−$330.5K−15.9%10.6K after
Aug 25, 2022 (view filing)Aug 23-242 daysHoge StephenPresidentSSale−10.0K$142.25−$1.42M−0.6%1.62M after2 lots
Aug 26, 2022 (view filing)Aug 24-252 daysBancel StephaneChief Executive OfficerSSale−80.0K$141.24−$11.3M−1.5%5.41M after8 lots
Aug 26, 2022 (view filing)Aug 251 dayBancel StephaneChief Executive OfficerSSale−10.0K$142.25−$1.42M−0.1%6.74M after
Aug 30, 2022 (view filing)Aug 291 dayHoge StephenPresidentSSale−1.12K$135.81−$152.0K−0.1%1.63M after
Aug 30, 2022 (view filing)Aug 291 dayAndres JuanSee remarksSSale−839$135.81−$113.9K−6.8%11.6K after
Sep 2, 2022 (view filing)Aug 312 daysAfeyan NoubarDirectorSSale−10.0K$136.95−$1.37M−0.4%2.44M after
Sep 2, 2022 (view filing)Aug 31-Sep 12 daysBancel StephaneChief Executive OfficerSSale−80.0K$133.71−$10.7M−1.5%5.41M after9 lots
Sep 2, 2022 (view filing)Sep 11 dayBancel StephaneChief Executive OfficerSSale−10.0K$131.13−$1.31M−0.1%6.73M after
Sep 9, 2022 (view filing)Sep 72 daysAfeyan NoubarDirectorSSale−10.0K$129.68−$1.30M−0.4%2.43M after
Sep 9, 2022 (view filing)Sep 7-82 daysBancel StephaneChief Executive OfficerSSale−80.0K$136.86−$10.9M−1.5%5.41M after8 lots
Sep 9, 2022 (view filing)Sep 81 dayBancel StephaneChief Executive OfficerSSale−10.0K$136.72−$1.37M−0.1%6.72M after
Sep 9, 2022 (view filing)Sep 81 dayKlinger Shannon ThymeChief Legal OfficerSSale−478$137.44−$65.7K−10.8%3.95K after
Sep 14, 2022 (view filing)Sep 12-132 daysHoge StephenPresidentSSale−6.97K$140.18−$977.3K−0.4%1.63M after2 lots
Sep 16, 2022 (view filing)Sep 142 daysAfeyan NoubarDirectorSSale−10.0K$134.00−$1.34M−0.4%2.42M after
Sep 16, 2022 (view filing)Sep 14-152 daysBancel StephaneChief Executive OfficerSSale−80.0K$137.97−$11.0M−1.5%5.41M after8 lots
Sep 16, 2022 (view filing)Sep 151 dayBancel StephaneChief Executive OfficerSSale−10.0K$138.62−$1.39M−0.1%6.71M after
Sep 23, 2022 (view filing)Sep 212 daysAfeyan NoubarDirectorSSale−10.0K$130.37−$1.30M−0.4%2.41M after
Sep 23, 2022 (view filing)Sep 21-222 daysBancel StephaneChief Executive OfficerSSale−80.0K$126.91−$10.2M−1.5%5.41M after9 lots
Sep 23, 2022 (view filing)Sep 221 dayBancel StephaneChief Executive OfficerSSale−10.0K$124.20−$1.24M−0.1%6.70M after
Sep 30, 2022 (view filing)Sep 282 daysAfeyan NoubarDirectorSSale−10.0K$123.58−$1.24M−0.4%2.40M after
Sep 30, 2022 (view filing)Sep 28-292 daysBancel StephaneChief Executive OfficerSSale−80.0K$119.92−$9.59M−1.5%5.41M after7 lots
Sep 30, 2022 (view filing)Sep 291 dayBancel StephaneChief Executive OfficerSSale−10.0K$119.82−$1.20M−0.1%6.69M after
Oct 7, 2022 (view filing)Oct 52 daysAfeyan NoubarDirectorSSale−10.0K$122.40−$1.22M−0.4%2.39M after
Oct 7, 2022 (view filing)Oct 5-62 daysBancel StephaneChief Executive OfficerSSale−80.0K$124.51−$9.96M−1.5%5.41M after8 lots
Oct 7, 2022 (view filing)Oct 61 dayBancel StephaneChief Executive OfficerSSale−10.0K$124.52−$1.25M−0.1%6.68M after
Oct 14, 2022 (view filing)Oct 122 daysAfeyan NoubarDirectorSSale−10.0K$135.36−$1.35M−0.4%2.38M after
Oct 14, 2022 (view filing)Oct 12-132 daysBancel StephaneChief Executive OfficerSSale−80.0K$132.77−$10.6M−1.5%5.41M after13 lots
Oct 14, 2022 (view filing)Oct 131 dayBancel StephaneChief Executive OfficerSSale−10.0K$126.51−$1.27M−0.1%6.67M after
Oct 21, 2022 (view filing)Oct 192 daysAfeyan NoubarDirectorSSale−10.0K$132.50−$1.32M−0.4%2.37M after